Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1595)
Reports (56)
SAGE documentation (225)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (275)
Americas (766)
Eastern Mediterranean (50)
Europe (707)
South-East Asia (81)
Western Pacific (200)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (69)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (131)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (50)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (71)
Yellow fever (42)
Zika (1)
Show more
4872 results found
2014
∙
PSC
Nomination of the members
2014
∙
Haut Conseil de la santé publique
Notice relating to adapting the immunisation strategy against invasive serogroup C meningococcal infections when facing a vaccine shortage
2014
∙
Haut Conseil de la santé publique
Notice relating to the accelerated immunisation schedules against hepatitis B using the 20 mg/1 ml ENGERIX B® and GENHEVAC B Pasteur 20 mg/0.5 ml vaccines
2014
∙
Haut Conseil de la santé publique
Notice relating to the booster vaccination against yellow fever for Guyana
2014
∙
Haut Conseil de la santé publique
Notice relating to the efficacy of the seasonal influenza vaccine in older people and to the place of healthcare professional immunisation in the influenza prevention strategy
2014
∙
Haut Conseil de la santé publique
Notice relating to the immunisation policy and to compulsory vaccinations in the general population (outside of professional settings and International Health Regulations) and to the lifting of financial obstacles to immunisation
2014
∙
Haut Conseil de la santé publique
Notice relating to the immunisation schedule with the MenBvac® vaccine and to the potential revaccination with Bexsero®
2014
∙
Haut Conseil de la santé publique
Notice relating to the issue of non-responders to hepatitis B immunisation
2014
∙
Haut Conseil de la santé publique
Notice relating to the minimum compulsory statements when publicising the diphtheria, tetanus, poliomyelitus and pertussis vaccine Repevax®
2014
∙
Haut Conseil de la santé publique
Notice relating to the minimum compulsory statements when publicising the seasonal influenza vaccine FluarixTetra®
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register